Answers are grounded in this paper and cite their sources.
Background and Aims: Spinal anaesthesia is an effective alternative technique for short-duration endoscopic urological procedures. Conventional 0.5% hyperbaric bupivacaine may be associated with prolonged motor blockade and haemodynamic instability, potentially delaying ambulation and discharge. This study aimed to compare the efficacy and safety of 0.25% and 0.5% hyperbaric bupivacaine for spinal anaesthesia in ambulatory endoscopic urological procedures. Methods: In this prospective, randomised, double-blind controlled study, 60 patients with American Society of Anesthesiologists physical status I and II undergoing elective lower urological endoscopic procedures were allocated into two groups ( n = 30 each). Group A received 5 mg of 0.25% hyperbaric bupivacaine (2 mL), and Group B received 10 mg of 0.5% hyperbaric bupivacaine (2 mL) intrathecally. The primary outcomes were onset and duration of sensory and motor block. Secondary outcomes included haemodynamic changes, postoperative pain assessed using the visual analogue scale (VAS), time to ambulation, and duration of stay in the post-anaesthesia care unit. Results: The onset of sensory block was faster and the duration of sensory and motor block was significantly longer in Group B ( P < 0.001). The ambulation time and post-anaesthesia care unit stay were significantly prolonged in Group B ( P < 0.001). Haemodynamic fluctuations were more frequent with 0.5% bupivacaine. Post-operative pain scores at 2 h were lower in Group B ( P < 0.001). Conclusion: Low-dose 0.25% hyperbaric bupivacaine provides effective spinal anaesthesia with improved haemodynamic stability, earlier ambulation, and faster recovery compared to 0.5% hyperbaric bupivacaine, making it suitable for ambulatory endoscopic urological procedures.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: